Skip to main content

Table 2 Incidences of Thromboembolic Complications

From: Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case–control study

 

FVIIa Group (n = 45)

Comparison Group (n = 34)

p-value

Troponin elevation

21 (47%)

14 (41%)

0.53

Clinically Significant Troponin Elevation (Troponin > 1.0 ng/dL)

6 (13%)

2 (6%)

0.52

New EKG changes

19 (42%)

6 (18%)

0.06

    T-wave abnormality

8 (18%)

1 (3%)

 

    ST abnormality

4 (9%)

3 (9%)

 

    Conduction block

1 (2%)

0

 

    Arrhythmia

3 (7%)

1 (3%)

 

    QTc prolongation

2 (5%)

1 (3%)

 

Troponin elevation with EKG Changes

2 (4%)

0

0.29

DVT/PE

1 (2%)

3 (9%)

0.18

Stroke

1 (2%)

0

0.38